linkovi











REFERENCE

  1. Foulds G, Johnson RB. Selection of dose regimens of azithromycin. Journal of Antimicrobial Chemotherapy 1993; 31(Suppl E): 39-50.
  2. Lode H et al. Azithromycin-review of key chemical, pharmacokinetic and microbiological features. Journal of Antimicrobial Chemotherapy 1996; 37 (Suppl. C): 1-8.
  3. Dunn CJ, Barradell LB. Azithromycin-a review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Drugs 1996; 51: 483-505.
  4. Ballow CH, Amsden GW, Martinez-Beltran MD, Larouche M. Azithromycin: The first azalide antibiotic. Annals of Pharmacotherapy 1992; 26: 1253-1261.
  5. Girard AE, Cimochowski CR, Faiella JA. Correlation of increased azithromycin levels with phagocyte infiltration into sites of infection. 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, 22-24 October 1990. Abstract 762.
  6. Retsema JA, Bergeron JM, Girard D, Milisen WB, Girard AE. Preferential concentration of azithromycin in an infected mouse thigh model. Journal of Antimicrobial Chemotherapy 1993; 31 (Suppl E):5-16
  7. Vannuffel P; Cocito C. Mechanism of action of streptogramins and macrolides. Drugs, 51 Suppl 1():20-30 1996
  8. O'Doherty B. An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections. J Antimicrob Chemother 1996; 37 (Suppl. C): 71-81.
  9. Klapan I, Culig J, Oreskovic K, Matrapazovski M, Radosevic S. Azithromycin Versus Amoxicillin/clavulanate in the treatment of acute sinusitis. American Journal of Otolaryngology, Vol 20, No1, 1999:pp 7-11
  10. Müller O. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections. J Antimicrob Chemother 1993; 31 (Suppl. E): 137-146.
  11. Biebuyck XA. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. The Journal of International Medical Research 1996; 24: 407-418.
  12. O'Doherty B, Müller O. A randomised multicenter study to compare the efficacy and toleration of azithromycin and clarithromycin in the treatment of adults with mild to moderate community acquired pneumonia. 8th ECCMID.
  13. Hamill J. Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. Journal of Antimicrobial Chemotherapy 1993; 31(Suppl E): 89-94.
  14. Arguedas AG, Loaiza C, Rodriguez F, Herrera M, Mohs E. Comparative Trial of 3 Days of Azithromycin Versus 10 Days of Clarithromycin in the Treatment of Children with Acute Otitis Media with Effusion. Journal of Chemotherapy. Vol. 9 - n. 1 (44-50) 1997.
  15. Lauvau DVA. Paediatric study comparint a 3-day regimen of azithromycin and a 5-10 day regimen of co-amoxiclav (amoxycillin clavulanate) in children with acute upper and/or lower respiratory tract infections. Presented at Third ICMAS, January 24-27 1996, Lisbon, Portugal.
  16. Müller O. An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections. Journal of Antimicrobial Chemotherapy 1996; 37 (Suppl. C): 83-92.
  17. Venuta A, Laudizi L, Beverelli A, Bettelli F, Milioli S, Garetti E. Azithromycin Compared with Clarithromycin for the Treament of Streptococcal Pharyngitis in Children. The Journal of International Medical Research 1998, 26: 152 - 158.
  18. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J (1992) 68 (Suppl. 3), S49 -S59.
  19. Cuchi T, Cuchi M, Aisa AM, Ferrer M, Bartolome M. Use and compliance with oral antibiotic treatment in children. Presented at Fourth ICMASK, January 21-23 1998, Barcelona, Spain.
  20. Grob P R. Antibiotic prescribing practices and patient compliance in the community. Scandinavian Journal of Infectious Diseases. 1992. 83: 7-14.
  21. Branthwaite A; Pechere J-C. Pan-European survey of patients' attitudes to antibiotics and antibiotic use. Journal of International Medical Research 1996. 24:229-238.
  22. Barsic B, Banaszak A. M. Matrapazovski M, Klinar I. Azithromycin, Clinical Safety And Tolerability. 9th European Congress of Clinical Microbiology and Infectious Diseases. Berlin 1999.
  23. Rapp P. R. Pharmacokinetics and Parmacodynamics of Intravenous and Oral Azithromycin: Enhanced Tissue Activity and Minimal Drug Interactions. The Annals of Pharmacotherapy. 1998. Vol 32.
  24. Heffelfinger JD. et al. : Management of Community Acquired Pneumonia in the Era of Pneumococcal Resistance, A Report from the Drug-Resistent Streptococcus pneumoniae Therapeutic Working Group, Arch Intern Med, 2000; 160:1399-1408.
  25. Pontani D. et al. : Efficacy and Toleration of Once-ddaily Azithromycin versus Twice-Daily Clarithromycin in Adult Community-Acquired Pneumonia, 5th ICMAS - program & abstracts, 2000, Seville, Spain.
  26. Umut S. et al. : Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor., J.Chemoter, 1999 Jun, 11:3, 211-4.
  27. Destache C.J. et al. : Clinical and economic conciderations in the treatment of acute exacerbations of chronic bronchitis, Journal of Antimicrobial Chemotherapy, 1999, 43, Suppl.A, 107-113.
  28. Barsic B. et al.: Azithromycin in the therapy of acute infectious exacerbation of chronic bronchitis: a meta analysis, 4th ICMASK, Barcelona, Spain, 1998.
  29. Rodriguez AF et al. Efficacy and safety of azithromycin in the treatment of pediatric patients with acute pharyngitis due to group A b-Hemolitic streptococci, 8th ECCMID, Lausanne, Switzerland, 1997.
  30. Esposito S. et al.: Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in Lower Respiratory Tract Infections in Pediatric Age, 5th ICMAS - program & abstracts, 2000, Seville, Spain.
  31. Esposito S. et al. : Mycoplasma pneumoniae and Chlamydia pneumoniae as Aetiological Agents of Recurrent Respiratory Tract Infections, 5th ICMAS - program & abstracts,2000,Seville,Spain.
  32. Alvarez-Elcoro S. et al. : The Macrolides : Erythromycin, Clarithromycin and Azithromycion. Mayo Clin Proc 1999; 74:613-634.
  33. D'Andrea Marcolino F.M. et al. : Open, Comparative Study of the Efficacy and Tolerability of Azithromycin versus Amoxycillin in Acute Rhinosinusitis in Adults, 5th ICMAS, 2000, Seville, Spain.
  34. Lellei I. et al.: Comparison of azithromycin and co-amoxiclav in acute sinusitis and acute otitis media in children. 5th ICMAS, 2000, Seville, Spain.
  35. Pechere JC; Lacey L. Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother, 2000 03, 45: 19-24
  36. Lode H et al. A Single -Blind, Multicentar Study of 3 Days Azithromycin versus 7 Days Roxithromycin in The Treatment of Lower Respiratory Tract Infections, ICMAS-KO 5, Seville, Spain
  37. Charlotte A. Kenreigh, and Linda Timm Wagner. Treatment of Community acquired Pneumonia: Optimizing Formulary decisions. www.medscape.com
  38. American Throacic Society. Guidelines for the Management of Adults with Community-acquired Pneumonia, Diagnosis, Assessment of Severity, Antimicrobial Therapy and Prevention. Am J Respir Crit Care Med 2001; 163:1730-54
  39. N. Sopena, C. Martinez-Vazouez, J.R. Rodriguez-Suarez, F. Segura Porta, A. Valencia Rodriguez, Open, Comparative Study of the Efficacy, Safety and Tolerance of Azithromycln vs Clarithromycin in the Treatment of Patients with Community Acquired Pneumonia, ICMASKO-5, Seville, Spain
  40. Amsden GW, Gray CL. Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. J Antimicrob Chemother. 2001
  41. Treadway G, Pontani, Agostino RD Jr. Azithromycin versus comparators in treatment of pediatric otitis media. 5th ICMAS - program & abstracts, 2000, Seville, Spain.
  42. Arguedas A. et al. : Comparative Trial of 3 Days of Azithromycin Versus 10 Days of Clarithromycin in the Treatment of Children with Acute Otitis Media with Effusion, Journal of Chemotherapy, 1997 Vol 9 N.1 (44-50)
  43. Slapak I. et al. : Azithromycin versus Clarithromycin : Clinical and Economic Comparison in the Treatment of Acute Otitis Media in Children. 5th ICMAS, 2000, Seville, Spain
  44. Harnett JP, Wilson J,. Systematic evidence review and mata-analysis of Azithromycin (AZ) randomized controlled trials (RCTs) in patients with acute exacerbation of chronic bronchitis (AECB), ICMASKO 6, Bologna, Italy, Jan 23-25, 2002; Abs no 8.27

Copyright 2001-2004 Pliva Hrvatska d.o.o. Sva prava pridržana.
O nama - Važne pravne informacije i uvjeti korištenja.
Zadnja izmjena:29.06.2004.